Albumin binding peptide-mediated disease targeting

Details for Australian Patent Application No. 2009322126 (hide)

Owner Abraxis BioScience, LLC

Inventors Trieu, Vuong

Agent Pizzeys

Pub. Number AU-A-2009322126

PCT Pub. Number WO2010/065950

Priority 61/170,368 17.04.09 US; 61/120,234 05.12.08 US

Filing date 7 December 2009

Wipo publication date 10 June 2010

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 51/08 (2006.01) Preparations containing radioactive substances for use in therapy or testing

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/065950 Priority application(s): WO2010/065950

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009322130-SPARC binding peptides and uses thereof

2009322122-Improved heat transfer between tracer and pipe